Tscan Therapeutics Inc Earnings

The next earnings date for Tscan Therapeutics Inc is August 10, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Tscan Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
08/10/2026	$-0.22

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Tscan Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/06/2026	Before Market	$-0.22	-25.43%
03/04/2026	Before Market	$-0.18	26.83%
11/12/2025	Before Market	$-0.28	7.04%
08/12/2025	Before Market	$-0.28	2.17%
05/06/2025	Before Market	$-0.26	10.87%
03/05/2025	Before Market	$-0.30	-7.45%
11/12/2024	Before Market	$-0.25	14.82%
08/12/2024	Before Market	$-0.28	2.95%
05/13/2024	Before Market	$-0.32	-22.32%
03/06/2024	Before Market	$-0.21	29.01%
11/09/2023	Before Market	$-0.24	47.94%
08/10/2023	Before Market	$-0.51	35.65%
05/10/2023	Before Market	$-0.93	-23.62%
03/08/2023	Before Market	$-0.78	-8.85%
11/09/2022	Before Market	$-0.67	8.77%
08/10/2022	Before Market	$-0.63	17.38%
05/09/2022	Before Market	$-0.67	9.40%
03/09/2022	Before Market	$-0.38	49.10%
11/10/2021	Before Market	$-0.80	-22.55%
08/19/2021	Before Market	$-7.69	-162.39%

More About Tscan Therapeutics Inc

Website

https://www.tscan.com

Country

USA

Full Time Employees

142

TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product is TSC-101, for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT), which is in Phase I clinical trial, as well as eliminates residual disease and promotes donor chimerism. It also develops TSC-102-A01 and TSC-102-A03, which are allogeneic and donor-derived TCR-T therapy candidates targeting epitopes. In addition, the company develops TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204 for the treatment of solid tumors. It has a research collaboration and license agreement with Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

“Tscan Therapeutics Inc Earnings” Can Refer to the Tscan Therapeutics Inc Earnings Date

Some people say “Tscan Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Tscan Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Tscan Therapeutics Inc Stock on the Earnings Date

If you own Tscan Therapeutics Inc stock (TCRX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Tscan Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Tscan Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Tscan Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Tscan Therapeutics Inc earnings or anything else related to the stock market.